This October 23, 2020 article was published in The American Medical Journal, and then republished on the same day at the NIH link. The article again supports our many previous posts suggesting the potential for an MMR vaccination to provide some protection against covid-19, and mitigate the severity of the disease. The article further supports the MMR vaccination is a potential explanation for mild and asymptomatic cases in children. Lax rates of MMR vaccination worldwide are correlated with worse rates and outcomes in covid-19.
While waiting for a covid-19 vaccine, it seems prudent and appropriate to initiate a strategy of MMR vaccination within covid-19 clusters and for health care personnel, to limit the spread, morbidity and mortality of covid-19 as much as possible. It is important to keep our own children’s MMR vaccinations up-to-date; and the general medical and scientific community, and the public should be made aware of the potential for an MMR booster in adults to provide partial protection against covid-19.
About the Author
